satavaptan has been researched along with cyclic gmp in 1 studies
| Studies (satavaptan) | Trials (satavaptan) | Recent Studies (post-2010) (satavaptan) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 95 | 11 | 30 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | satavaptan (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boone, M; Deen, PM; Kortenoeven, M; Robben, JH | 1 |
1 other study(ies) available for satavaptan and cyclic gmp
| Article | Year |
|---|---|
Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine; Arginine Vasopressin; Atrial Natriuretic Factor; Cell Line; Cells, Cultured; Cyclic GMP; Diabetes Insipidus, Nephrogenic; Humans; Kidney Tubules, Collecting; Male; Models, Animal; Morpholines; Protein Biosynthesis; Receptors, Vasopressin; Signal Transduction; Spiro Compounds | 2010 |